physostigmine heptyl has been researched along with physostigmine in 70 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (4.29) | 18.7374 |
1990's | 52 (74.29) | 18.2507 |
2000's | 11 (15.71) | 29.6817 |
2010's | 2 (2.86) | 24.3611 |
2020's | 2 (2.86) | 2.80 |
Authors | Studies |
---|---|
Chen, YL; Dunaiskis, A; Hedberg, K; Ives, J; Johnson, J; Jones, S; Liston, D; Nielsen, J; Russo, L | 1 |
Chapin, D; Chen, YL; Dunaiskis, A; Hedberg, K; Ives, J; Johnson, J; Jones, S; Liston, D; Nielsen, J | 1 |
Brossi, A; Greig, NH; Holloway, HW; Whittaker, NF; Yu, QS; Zhu, X | 1 |
Alley, GM; Brossi, A; Deschamps, JR; Greig, NH; Holloway, HW; Kulkarni, SS; Lahiri, DK; Luo, W; Parrish, D; Yu, QS; Zhan, M | 1 |
Brossi, A; Greig, NH; Holloway, HW; Kulkarni, SS; Lahiri, DK; Luo, W; Parrish, DA; Shafferman, A; Tweedie, D; Yu, QS | 1 |
Chaudhaery, SS; Nath, C; Nazir, A; Roy, KK; Sammi, SR; Saxena, AK; Saxena, G; Shakya, N | 1 |
Andrisano, V; Bartolini, M; Belluti, F; Bisi, A; Di Marzo, V; Gobbi, S; Ligresti, A; Montanari, S; Mor, M; Rampa, A; Rivara, S; Scalvini, L | 1 |
Li, X; Wang, S; Wang, Y; Wang, Z; Zhang, H | 1 |
Brossi, A; Garofalo, P; Greig, NH; Heller, B; Iijima, S; Ingram, DK; Spangler, EL | 1 |
Constanzer, ML; Herold, ML; Matuszewski, BK | 1 |
Becker, RE; Moriearty, PL | 1 |
Giacobini, E; Messamore, E; Ogane, N | 1 |
Brazell, C; Heald, A; Iversen, SD; Pagella, PG; Rupniak, NM; Tye, SJ | 1 |
Becker, RE; Unni, LK | 1 |
Arnerić, SP; Giacobini, E; Linville, DG | 1 |
Becker, RE; Hutt, V; Imbimbo, BP; Unni, LK | 1 |
De Sarno, P; Giacobini, E; Pomponi, M; Tang, XC; Williams, E | 1 |
Brufani, M; Castellano, C; Marta, M; Oliverio, A; Pagella, PG; Pavone, F; Pomponi, M; Rugarli, PL | 1 |
Brufani, M; Marta, M; Pomponi, M | 1 |
Cuadra, G; Giacobini, E | 2 |
Arison, B; Chen, TS; Cheng, H; Monaghan, R; Petuch, B; Schwartz, MS; So, L; White, R | 1 |
Fusi, F; Giacobini, E; Lai, CC; Mori, F | 1 |
Giustina, A; Imbimbo, BP; Licini, M; Mosca, A; Onelli, E; Schettino, M; Zecca, L | 1 |
Imbimbo, BP; Luzzana, M; Mosca, A; Onelli, E; Paleari, R; Rosti, E | 1 |
Thal, LJ; Waite, JJ | 1 |
Brufani, M; Filocamo, L; Imbriani, E; Lappa, S; Mannina, L | 1 |
Barchowsky, A; Block, GA; Cutler, NR; Reines, SA; Sawin, SF; Sramek, JJ | 1 |
Cuadra, G; Giacobini, E; Summers, K | 1 |
Becker, RE; Latham, G; Martinez, R; Potter, W; Radcliffe, J; Sunderland, T; Unni, LK | 1 |
Dawson, GR; Iversen, SD | 1 |
Giacobini, E; Messamore, E; Warpman, U; Williams, E | 1 |
Bondiolotti, GP; Cattaneo, L; Cocchi, D; Muller, EE | 1 |
Auteri, A; Imbimbo, BP; Lattuada, N; Luzzana, M; Mosca, A; Radice, D; Zecca, L | 1 |
Heuser, D; Hudgell, R; Imbimbo, BP; Romero, E; Scremin, AM; Scremin, OU | 1 |
Cella, SG; Imbimbo, BP; Müller, EE; Pieretti, F | 1 |
Mosca, A; Pagella, PG; Radice, D; Zecca, L | 1 |
Auteri, A; Cazzola, E; Imbimbo, BP; Lattuada, N; Luzzana, M; Mosca, A; Radice, D; Zecca, L | 1 |
Giacobini, E; Messamore, E; Ogane, N; Warpman, U | 1 |
Cutler, NR; Sramek, JJ | 2 |
Giacobini, E; Lai, CC; Mori, F | 1 |
Camacho, F; Smith, CP; Vargas, HM; Winslow, JT | 1 |
Braida, D; Griffini, P; Lamperti, M; Maggi, A; Paladini, E; Sala, M | 1 |
Canal, N; Imbimbo, BP | 1 |
Ghezzi, A; Imbimbo, BP; Luzzana, M; Mosca, A; Paleari, R | 1 |
Hänninen, O; Kaliste-Korhonen, E; Raushel, FM; Tuovinen, K | 3 |
Jenden, DJ; Li, MG; Scremin, AM; Scremin, OU | 1 |
Garrone, B; Landolfi, C; Luparini, MR; Magnani, M; Milanese, C; Tolu, L | 1 |
Bjornsson, TD; Imbimbo, BP; Troetel, WM | 1 |
Imbimbo, BP; Mant, T; Troetel, WM | 1 |
Alberoni, M; Imbimbo, BP; Lucca, U; Lucchelli, F; Thal, LJ | 1 |
Calcagnini, G; Fieschi, C; Frontoni, M; Giubilei, F; Imbimbo, BP; Lino, S; Santini, M; Strano, S; Tisei, P | 1 |
Scheltens, P; Verhey, FR | 1 |
Imbimbo, BP; Lucca, U; Lucchelli, F; Martelli, P; Thal, LJ; Troetel, WM | 1 |
Cross, AJ; De Souza, RJ; Green, AR; Misra, A; Murray, TK; Snape, MF; Williams, JL | 1 |
Loizzo, A; Luzi, M; Palazzesi, S; Pomponi, M; Tebano, MT | 1 |
Hänninen, O; Tuovinen, K | 1 |
Kása, P; Rakonczay, Z; Török, L | 1 |
Braida, D; Ottonello, F; Sala, M; Virag, W | 1 |
Braida, D; Sala, M | 2 |
Braida, D; Ottonello, F; Sala, M | 2 |
Campanella, L; Cocco, R; Favero, G; Sammartino, MP; Tomassetti, M | 1 |
Rakonczay, Z | 1 |
Chapin, D; Hubbard, ST; Jones, SB; Liston, DR; Nason, D; Nielsen, JA; Ramirez, A; Shalaby, IA; Villalobos, A; White, WF | 1 |
Freund, JR; Gopallawa, I; Lee, RJ | 1 |
2 review(s) available for physostigmine heptyl and physostigmine
Article | Year |
---|---|
Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Humans; Ligands | 2022 |
Eptastigmine: ten years of pharmacology, toxicology, pharmacokinetic, and clinical studies.
Topics: Acetylcholine; Acetylcholinesterase; Activities of Daily Living; Agranulocytosis; Alzheimer Disease; Animals; Behavior, Animal; Biogenic Monoamines; Brain; Cholinesterase Inhibitors; Cognition Disorders; Erythrocytes; Humans; Learning; Memory; Physostigmine; Randomized Controlled Trials as Topic | 2001 |
9 trial(s) available for physostigmine heptyl and physostigmine
Article | Year |
---|---|
Relationship between pharmacokinetics and pharmacodynamics of eptastigmine in young healthy volunteers.
Topics: Adult; Cholinesterase Inhibitors; Cholinesterases; Chromatography, High Pressure Liquid; Cross-Over Studies; Double-Blind Method; Erythrocytes; Humans; Male; Physostigmine | 1995 |
A patient-side technique for real-time measurement of acetylcholinesterase activity during monitoring of eptastigmine treatment.
Topics: Acetylcholinesterase; Adolescent; Adult; Alzheimer Disease; Cholinesterase Inhibitors; Double-Blind Method; Drug Monitoring; Female; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Physostigmine; Reproducibility of Results | 1995 |
A multiple-dose safety trial of eptastigmine in Alzheimer's disease, with pharmacodynamic observations of red blood cell cholinesterase.
Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Erythrocytes; Female; Humans; Male; Middle Aged; Physostigmine; Placebos | 1995 |
The target population in phase I clinical trials of cholinergic compounds in Alzheimer disease: the role of the "bridging study".
Topics: Alzheimer Disease; Cholinergic Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Physostigmine; Safety; Tacrine | 1995 |
Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer's disease. Eptastigmine Study Group.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Double-Blind Method; Drug Administration Schedule; Erythrocytes; Female; Humans; Male; Middle Aged; Physostigmine | 1996 |
Effect of food on the absorption of eptastigmine.
Topics: Acetylcholinesterase; Administration, Oral; Adolescent; Adult; Area Under Curve; Butyrylcholinesterase; Cholinesterase Inhibitors; Cross-Over Studies; Dizziness; Double-Blind Method; Food; Headache; Humans; Male; Physostigmine; Treatment Outcome | 1998 |
Maximum tolerated dose and pharmacodynamics of eptastigmine in elderly healthy volunteers.
Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Physostigmine | 1998 |
A 25-week placebo-controlled study of eptastigmine in patients with Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Physostigmine; Treatment Outcome | 1998 |
Efficacy and safety of eptastigmine for the treatment of patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Physostigmine; Treatment Outcome | 1999 |
59 other study(ies) available for physostigmine heptyl and physostigmine
Article | Year |
---|---|
Syntheses, resolution, and structure-activity relationships of potent acetylcholinesterase inhibitors: 8-carbaphysostigmine analogues.
Topics: Animals; Brain; Cholinesterase Inhibitors; Lethal Dose 50; Male; Mice; Physostigmine; Structure-Activity Relationship | 1992 |
Syntheses and anticholinesterase activity of tetrahydrobenzazepine carbamates.
Topics: Administration, Oral; Amnesia; Animals; Avoidance Learning; Benzazepines; Carbamates; Cholinesterase Inhibitors; Cholinesterases; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Magnetic Resonance Spectroscopy; Male; Mice | 1994 |
Anticholinesterase activity of compounds related to geneserine tautomers. N-Oxides and 1,2-oxazines.
Topics: Acetylcholinesterase; Alkaloids; Butyrylcholinesterase; Cholinesterase Inhibitors; Cyclic N-Oxides; Humans; Isomerism; Oxazines; Structure-Activity Relationship | 2002 |
Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine.
Topics: Acetylcholinesterase; Amyloid beta-Protein Precursor; Benzofurans; Butyrylcholinesterase; Carbamates; Cell Line; Cell Survival; Cholinesterase Inhibitors; Crystallography, X-Ray; Humans; Models, Molecular; Molecular Structure; Neurons; Oxepins; Structure-Activity Relationship | 2005 |
Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine.
Topics: Acetophenones; Acetylcholinesterase; Animals; Benzofurans; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Crystallography, X-Ray; Furans; Heterocyclic Compounds, 3-Ring; Humans; Models, Molecular; Oxepins; Stereoisomerism; Structure-Activity Relationship; Torpedo | 2006 |
Novel carbamates as orally active acetylcholinesterase inhibitors found to improve scopolamine-induced cognition impairment: pharmacophore-based virtual screening, synthesis, and pharmacology.
Topics: Acetylcholinesterase; Administration, Oral; Animals; Avoidance Learning; Caenorhabditis elegans; Carbamates; Catalytic Domain; Cholinesterase Inhibitors; Databases, Factual; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Male; Mice; Models, Molecular; Nootropic Agents; Quantitative Structure-Activity Relationship; Scopolamine | 2010 |
Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents.
Topics: Acetylcholinesterase; Alzheimer Disease; Amidohydrolases; Butyrylcholinesterase; Carbamates; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2016 |
The long-acting cholinesterase inhibitor heptyl-physostigmine attenuates the scopolamine-induced learning impairment of rats in a 14-unit T-maze.
Topics: Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Electroshock; Erythrocytes; Learning; Male; Physostigmine; Rats; Rats, Inbred F344; Scopolamine | 1992 |
Determination of picogram levels of heptylphysostigmine in human plasma using high-performance liquid chromatography with fluorescence detection.
Topics: Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Electrochemistry; Humans; Physostigmine; Reproducibility of Results; Spectrometry, Fluorescence | 1992 |
Inhibition of human brain and RBC acetylcholinesterase (AChE) by heptylphysostigmine (HPTL).
Topics: Acetylcholinesterase; Brain; Cholinesterase Inhibitors; Cholinesterase Reactivators; Dichlorvos; Erythrocytes; Humans; Hydrogen-Ion Concentration; Physostigmine; Pralidoxime Compounds | 1992 |
Preferential inhibition of acetylcholinesterase molecular forms in rat brain.
Topics: Acetylcholinesterase; Animals; Brain; Centrifugation, Density Gradient; Cholinesterase Inhibitors; Detergents; Isoflurophate; Macromolecular Substances; Male; Neostigmine; Octoxynol; Physostigmine; Polyethylene Glycols; Rats; Rats, Inbred Strains; Solubility; Water | 1992 |
Reversal of cognitive impairment by heptyl physostigmine, a long-lasting cholinesterase inhibitor, in primates.
Topics: Acetylcholinesterase; Analysis of Variance; Animals; Body Temperature Regulation; Cholinesterase Inhibitors; Cognition; Dose-Response Relationship, Drug; Erythrocyte Membrane; Macaca mulatta; Male; Memory; Physostigmine; Reference Values; Saimiri; Scopolamine; Time Factors | 1992 |
Determination of heptylphysostigmine in plasma by high-performance liquid chromatography with electrochemical detection.
Topics: Cholinesterase Inhibitors; Cholinesterases; Chromatography, High Pressure Liquid; Electrochemistry; Humans; Physostigmine | 1992 |
Heptyl-physostigmine enhances basal forebrain control of cortical cerebral blood flow.
Topics: Animals; Cerebral Cortex; Cerebrovascular Circulation; Cholinesterase Inhibitors; Electric Stimulation; Male; Parasympathetic Nervous System; Physostigmine; Prosencephalon; Rats; Rats, Inbred Strains; Stimulation, Chemical | 1992 |
Kinetics of cholinesterase inhibition by eptastigmine in man.
Topics: Adult; Alzheimer Disease; Cholinesterase Inhibitors; Humans; Kinetics; Male; Physostigmine | 1991 |
The effect of heptyl-physostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat.
Topics: Acetylcholinesterase; Animals; Cholinergic Fibers; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Erythrocytes; Male; Physostigmine; Rats; Rats, Inbred Strains | 1989 |
A long-lasting cholinesterase inhibitor affecting neural and behavioral processes.
Topics: Acetylcholinesterase; Animals; Avoidance Learning; Behavior, Animal; Brain; Cerebral Cortex; Exploratory Behavior; Kinetics; Male; Mice; Mice, Inbred DBA; Physostigmine; Rats; Rats, Inbred Strains; Reaction Time | 1987 |
Anticholinesterase activity of a new carbamate, heptylphysostigmine, in view of its use in patients with Alzheimer-type dementia.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Cholinesterase Inhibitors; Eels; In Vitro Techniques; Kinetics; Mathematics; Physostigmine | 1986 |
Effects of cholinesterase inhibitors and clonidine coadministration on rat cortex neurotransmitters in vivo.
Topics: Acetylcholine; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Clonidine; Dialysis; Dopamine; Drug Interactions; Male; Neurotransmitter Agents; Norepinephrine; Physostigmine; Rats; Rats, Sprague-Dawley; Serotonin | 1995 |
Microbial transformation of N-heptyl physostigmine, a semisynthetic alkaloid inhibitor of cholinesterase.
Topics: Acremonium; Biotransformation; Cholinesterase Inhibitors; Mitosporic Fungi; Physostigmine | 1995 |
Cholinesterase inhibitors increase secretion of APPs in rat brain cortex.
Topics: Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Bethanechol; Cerebral Cortex; Cholinesterase Inhibitors; Dichlorvos; Electric Stimulation; In Vitro Techniques; Male; Physostigmine; Rats; Rats, Sprague-Dawley | 1995 |
Coadministration of cholinesterase inhibitors and idazoxan: effects of neurotransmitters in rat cortex in vivo.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Dioxanes; Dopamine; Drug Synergism; Idazoxan; Male; Microdialysis; Neurotransmitter Agents; Norepinephrine; Physostigmine; Rats; Rats, Sprague-Dawley; Serotonin | 1995 |
The behavioral effects of heptylphysostigmine on rats lesioned in the nucleus basalis.
Topics: Acetylcholinesterase; Acoustic Stimulation; Animals; Basal Ganglia; Behavior, Animal; Brain; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Exploratory Behavior; Learning; Male; Maze Learning; Memory; Motor Activity; Physostigmine; Psychomotor Performance; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Reflex, Startle; Space Perception | 1995 |
Synthesis of 2'-heptylcarbamoyloxy-2-methyl-6,7-benzomorphan: a new analogue of heptylphysostigmine (MF 201).
Topics: Benzomorphans; Cholinesterase Inhibitors; Physostigmine | 1994 |
Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo.
Topics: Acetylcholine; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Dialysis; Dopamine; Dose-Response Relationship, Drug; Extracellular Space; Injections, Subcutaneous; Male; Neurotransmitter Agents; Norepinephrine; Perfusion; Physostigmine; Rats; Rats, Sprague-Dawley; Serotonin; Sodium Chloride | 1994 |
Oral administration of heptylphysostigmine in healthy volunteers: a preliminary study.
Topics: Administration, Oral; Adolescent; Adult; Cholinesterase Inhibitors; Cholinesterases; Drug Administration Schedule; Erythrocytes; Half-Life; Humans; Male; Physostigmine | 1994 |
The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory.
Topics: Animals; Avoidance Learning; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cholinesterase Inhibitors; Conditioning, Classical; Discrimination Learning; Donepezil; Dose-Response Relationship, Drug; Indans; Learning; Memory; Mice; Oxadiazoles; Pain Threshold; Parasympathomimetics; Physostigmine; Piperidines; Pyrazines; Quinuclidines; Rats; Receptors, Muscarinic; Thiophenes | 1993 |
Muscarinic receptors mediate attenuation of extracellular acetylcholine levels in rat cerebral cortex after cholinesterase inhibition.
Topics: Acetylcholine; Animals; Atropine; Cerebral Cortex; Cholinesterase Inhibitors; Dialysis; Extracellular Space; Male; Physostigmine; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic | 1993 |
Effect of acute and short-term administration of cholinomimetic drugs on corticosterone secretion in the rat.
Topics: Analysis of Variance; Animals; Cholinesterase Inhibitors; Cholinesterases; Corticosterone; Glycerylphosphorylcholine; Hypothalamo-Hypophyseal System; Male; Oximes; Parasympathomimetics; Physostigmine; Pituitary-Adrenal System; Pyridines; Radioimmunoassay; Rats; Rats, Inbred WKY | 1993 |
Pharmacodynamics and pharmacokinetics of eptastigmine in elderly subjects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Cholinesterases; Erythrocytes; Female; Half-Life; Humans; Male; Middle Aged; Physostigmine | 1993 |
Prolonged effects of cholinesterase inhibition with eptastigmine on the cerebral blood flow-metabolism ratio of normal rats.
Topics: Animals; Brain; Cerebrovascular Circulation; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Glucose; Male; Physostigmine; Rats; Rats, Wistar; Reference Values; Regression Analysis; Time Factors | 1993 |
Eptastigmine augments basal and GHRH-stimulated growth hormone release in young and old dogs.
Topics: Aging; Animals; Cholinesterase Inhibitors; Cholinesterases; Dogs; Dose-Response Relationship, Drug; Female; Growth Hormone; Male; Physostigmine | 1993 |
Determination of heptylphysostigmine in plasma by high-performance liquid chromatography with electrochemical detection.
Topics: Acetylcholinesterase; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Electrochemistry; Erythrocytes; Humans; Physostigmine | 1993 |
Rapid potentiometric determination of cholinesterases in plasma and red cells: application to eptastigmine monitoring.
Topics: Administration, Oral; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Cholinesterases; Drug Monitoring; Erythrocytes; Humans; Hydrogen-Ion Concentration; Middle Aged; Physostigmine; Potentiometry | 1993 |
Cholinesterase inhibitor effects on extracellular acetylcholine in rat cortex.
Topics: Acetylcholine; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Dialysis; Electrochemistry; Extracellular Space; Male; Physostigmine; Rats; Rats, Sprague-Dawley; Tacrine | 1993 |
Scientific and ethical concerns in clinical trials in Alzheimer's patients: the bridging study.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials as Topic; Dihydropyridines; Ethics, Medical; Humans; Nootropic Agents; Oximes; Physostigmine; Psychotropic Drugs; Pyridines; Tacrine; Thiadiazoles | 1995 |
The effect of cholinesterase inhibitors on the secretion of APPS from rat brain cortex.
Topics: Amyloid beta-Protein Precursor; Animals; Bethanechol; Cerebral Cortex; Cholinesterase Inhibitors; Dichlorvos; Electric Stimulation; In Vitro Techniques; Physostigmine; Rats; Solubility | 1996 |
Alpha 2-adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat.
Topics: Adrenergic alpha-Antagonists; Animals; Avoidance Learning; Benzazepines; Cholinesterase Inhibitors; Drug Synergism; Galantamine; Idazoxan; Male; Physostigmine; Rats; Rats, Sprague-Dawley; Tacrine; Yohimbine | 1996 |
An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors.
Topics: Amnesia; Analysis of Variance; Animals; Behavior, Animal; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Indans; Male; Maze Learning; Motor Activity; Muscarinic Antagonists; Physostigmine; Piperidines; Rats; Rats, Wistar; Scopolamine; Tacrine | 1996 |
Pharmacodynamic monitoring of eptastigmine in capillary blood.
Topics: Acetylcholinesterase; Adult; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Male; Middle Aged; Physostigmine; Time Factors | 1996 |
Eptastigmine-phosphotriesterase combination in DFP intoxication.
Topics: Animals; Antidotes; Aryldialkylphosphatase; Behavior, Animal; Cholinesterase Inhibitors; Drug Therapy, Combination; Esterases; Isoflurophate; Male; Mice; Mice, Inbred Strains; Physostigmine | 1996 |
Phosphotriesterase, pralidoxime-2-chloride (2-PAM) and eptastigmine treatments and their combinations in DFP intoxication.
Topics: Animals; Antidotes; Aryldialkylphosphatase; Brain; Cholinesterase Inhibitors; Esterases; Isoflurophate; Male; Mice; Physostigmine; Pralidoxime Compounds | 1996 |
Cholinesterase inhibition improves blood flow in the ischemic cerebral cortex.
Topics: Animals; Cerebral Cortex; Cholinesterase Inhibitors; Ischemia; Male; Physostigmine; Rats; Rats, Sprague-Dawley; Regional Blood Flow | 1997 |
Effect of the subchronic treatment with the acetylcholinesterase inhibitor heptastigmine on central cholinergic transmission and memory impairment in aged rats.
Topics: Acetylcholinesterase; Aging; Animals; Behavior, Animal; Brain; Cholinesterase Inhibitors; Cognition; Male; Memory Disorders; Parasympathetic Nervous System; Physostigmine; Rats; Rats, Wistar; Space Perception; Synaptic Transmission | 1998 |
Cardiac autonomic dysfunction in patients with Alzheimer disease: possible pathogenetic mechanisms.
Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Autonomic Nervous System; Autonomic Nervous System Diseases; Cholinesterase Inhibitors; Electrocardiography; Erythrocytes; Female; Fourier Analysis; Heart; Heart Rate; Humans; Male; Middle Aged; Physostigmine; Signal Processing, Computer-Assisted | 1998 |
[Drugs for Alzheimer disease: what will the minister decide].
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Cholinesterase Inhibitors; Drug Approval; Female; Health Policy; Humans; Male; Middle Aged; Netherlands; Neurobehavioral Manifestations; Physostigmine; Religion and Medicine | 1998 |
A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066.
Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Carbachol; Cholinesterase Inhibitors; Donepezil; Drug Evaluation, Preclinical; Humans; Indans; Indoles; Injections, Intraperitoneal; Isoquinolines; Logistic Models; Male; Physostigmine; Piperidines; Rats; Structure-Activity Relationship; Tacrine; Tumor Cells, Cultured | 1999 |
Success of pyridostigmine, physostigmine, eptastigmine and phosphotriesterase treatments in acute sarin intoxication.
Topics: Animals; Antidotes; Aryldialkylphosphatase; Esterases; Lethal Dose 50; Male; Mice; Physostigmine; Pyridostigmine Bromide; Sarin | 1999 |
Effects of cholinergic drugs on neocortical EEG and flash-visual evoked potentials in the mouse.
Topics: Animals; Cholinesterase Inhibitors; Electroencephalography; Evoked Potentials, Visual; Fourier Analysis; Male; Mice; Mice, Inbred DBA; Neocortex; Physostigmine | 1999 |
Protection of mice against soman by pretreatment with eptastigmine and physostigmine.
Topics: Animals; Atropine; Blood-Brain Barrier; Brain; Cerebellum; Cholinesterase Inhibitors; Convulsants; Lethal Dose 50; Lung; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Physostigmine; Soman | 1999 |
Preferential inhibition of acetylcholinesterase molecular forms in normal human brain.
Topics: Acetylcholinesterase; Benzazepines; Brain; Cholinesterase Inhibitors; Humans; Physostigmine; Tacrine | 1999 |
Excitatory and inhibitory effects of second-generation cholinesterase inhibitors on rat gastrointestinal transit.
Topics: Administration, Oral; Animals; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Gastrointestinal Transit; Hydrocarbons, Brominated; Indans; Male; Physostigmine; Piperidines; Pirenzepine; Rats; Rats, Wistar; Receptor, Muscarinic M1; Receptors, Muscarinic; Receptors, Nicotinic; Scopolamine; Tacrine | 2000 |
Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats.
Topics: Animals; Behavior, Animal; Cannabinoids; Cholinesterase Inhibitors; Cyclohexanols; Male; Maze Learning; Memory; Memory Disorders; Motor Activity; Physostigmine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Rimonabant | 2000 |
Eptastigmine improves eight-arm radial maze performance in aged rats.
Topics: Animals; Cholinesterase Inhibitors; Male; Maze Learning; Motor Activity; Physostigmine; Rats; Rats, Wistar | 2000 |
Eptastigmine restores the aged rat's normal cortical spectral power pattern.
Topics: Administration, Oral; Aging; Animals; Cholinesterase Inhibitors; Electroencephalography; Male; Motor Activity; Physostigmine; Rats; Rats, Wistar | 2000 |
Eptastigmine, nicotinamide and nicotinic acid determination using an inhibition enzyme sensor; application to pharmaceutical analysis.
Topics: Biological Assay; Cholinesterase Inhibitors; Niacin; Niacinamide; Pharmaceutical Preparations; Physostigmine; Vasodilator Agents | 2002 |
Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain.
Topics: Acetylcholinesterase; Alzheimer Disease; Benzazepines; Brain; Butyrylcholinesterase; Carbamates; Cerebral Cortex; Cholinesterase Inhibitors; Edrophonium; Humans; In Vitro Techniques; Phenylcarbamates; Physostigmine; Rivastigmine; Tacrine; Trichlorfon | 2003 |
Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease.
Topics: Acetylcholine; Alzheimer Disease; Animals; Brain; Butyrylcholinesterase; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Humans; Indans; Male; Mice; Physostigmine; Piperidines; Rats; Rats, Sprague-Dawley; Tacrine | 2004 |
Bitter taste receptors stimulate phagocytosis in human macrophages through calcium, nitric oxide, and cyclic-GMP signaling.
Topics: Calcium; Cell Communication; Cells, Cultured; Coculture Techniques; Cyclic GMP; Epithelial Cells; Humans; Macrophages; Monocytes; Nitric Oxide; Nitric Oxide Synthase Type III; Pertussis Toxin; Phagocytosis; Physostigmine; Quinolones; Receptors, G-Protein-Coupled; Signal Transduction | 2021 |